Daten und Fakten 2011 - Universitätsspital Basel

96
Bereich Medizin
Dettenkofer M, Ammon A, Astagneau P, Dancer SJ, Gastmeier P, Harbarth S, Humphreys
H, Kern WV, Lyytikäinen O, Sax H, Voss A, Widmer AF. Infection control -a
European research perspective for the next decade. J Hosp Infect. 77(1):7-10, 2011
Elzi L, Steffen I, Furrer H, Fehr J, Cavassini M, Hirschel B, Hoffmann M, Bernasconi
E, Bassetti S, Battegay M. Improved sensitivity of an interferon-gamma release assay
(T-SPOT.TB) in combination with tuberculin skin test for the diagnosis of latent tuberculosis
in the presence of HIV co-Infection. BMC Infect Dis. Nov 15;11(1):319, 2011
John AK, Schmaler M, Khanna N, Landmann R. Reversible daptomycin tolerance of
adherent staphylococci in an implant infection model. Antimicrob Agents Chemother.
Jul;55(7):3510-6, 2011
Kaufmann GR, Elzi L, Weber R, Furrer H, Giulieri S, Vernazza P, Bernasconi E,
Hirschel B, Battegay M; Swiss HIV Cohort Study. Interruptions of cART limits CD4 T-
cell recovery and increases the risk for opportunistic complications and death. AIDS.
25(4):441-51, 2011
Khanna N, Stuehler C, Conrad B, Lurati S, Krappmann S, Einsele H, Berges C, Topp
MS. Generation of a multipathogen-specific T-cell product for adoptive immunotherapy
based on activation-dependent expression of CD154. Blood. 118(4):1121-31,
2011.
Marzolini C, Back D, Weber R, Furrer H, Cavassini M, Calmy A, Vernazza P, Bernasconi
E, Khoo S, Battegay M, Elzi L; Swiss HIV Cohort Study Members. Ageing with
HIV: medication use and risk for potential drug-drug interactions. J Antimicrob Chemother.
2011 Sep;66(9):2107-11.
Mossdorf E, Marzolini C, Fasel D, Mello Fayet A, Blum C, Donath M, Battegay M.
Drug-drug interactions with antiretroviral medicaments.
Praxis (Bern 1994). 2011 Sep 21;100(19):1193-6.
Mossdorf E, Stoeckle M, Mwaigomole EG, Chiweka E, Kibatala PL, Geubbels E,
Urassa H, Abdulla S, Elzi L, Tanner M, Furrer H, Hatz C, Battegay M. Improved antiretroviral
treatment outcome in a rural African setting is associated with cART initiation
at higher CD4 cell counts and better general health condition. BMC Infect Dis.
11:98, 2011
Schneider T, Halter J, Heim D, Passweg J, Stern M, Tichelli A, Weisser M, Gerull S.
Pre-emptive diagnosis and treatment of fungal infections-evaluation of a single-centre
policy. Clin Microbiol Infect. May 31, 2011
Stuehler C, Khanna N, Bozza S, Zelante T, Moretti S, Kruhm M, Lurati S, Conrad B,
Worschech E, StevanoviÝ S, Krappmann S, Einsele H, Latgé JP, Loeffler J, Romani L,
Topp MS. Cross-protective TH1 immunity against Aspergillus fumigatus and Candida
albicans. Blood. 117(22):5881-91, 2011.